Abstract: Endodontic medicine, which addresses the bidirectional relationship between endodontic infections and systemic diseases, has gained prominence in the field of endodontics. There is much evidence showing that while systemic disease may influence the pathogenesis of endodontic infection, endodontic infection can also cause systemic alterations. These alterations include more severe bone resorption and inflammation in the periapical area as well as enhanced systemic disease symptoms. Similarly, many reports have described the impact of systemic diseases on the tissue responses to dental materials. Conversely, the local use of dental materials may show systemic effects in the form of altered production of biomarkers. Thus, studies to better understand the mechanisms related to those connections are extremely important. In this context, the objective of this review was to analyze and discuss the current literature regarding the connections among these three factors-systemic diseases, endodontic infection, and endodontic dental materials-and determine how these connections may interfere in the systemic health status and the endodontic treatment outcomes, which are represented by periapical wound healing.
Introduction
Endodontic infection may be described as bacterial colonization of the root canals, which occurs because of pulp exposure caused primarily by caries or dental trauma. Thus, apical periodontitis (AP) is an outcome of endodontic infection and is characterized by bone degradation in response to intracanal bacterial infection. Bone loss occurs as a host defense mechanism against infection. 1 In the AP scenario, several proinflammatory cytokines are produced locally to mediate the immune response. This "cytokine storm" is related to the inflammatory process, bone resorption, and development of AP. 2, 3 AP is known to have multiple adverse effects, including pain, loss of bone support, and even loss of the tooth. However, many investigators have attempted to determine the consequences of AP since it is a Declaration of Interests: The authors certify that they have no commercial or associative interest that represents a conflict of interest in connection with the manuscript.
focus of infection, i.e., it is connected with the body system through blood vessels. 4, 5 These studies have emphasized the role of AP in systemic alterations in addition to the obvious local inflammation. 6, 7 Consequently, studies have been performed to answer the following question: Does endodontic infection alter systemic health status?
Thus, one of the objectives of this review was to analyze and discuss the current literature regarding the bidirectional relationship between endodontic infection and systemic diseases. Endodontic therapy aims to eliminate endodontic infection through the removal of microorganisms from the root canal system by cleaning and shaping, 8 in addition to promoting the re-establishment of periapical tissues by using an inert and biocompatible material. 9 However, previous studies have already described that the chemical composition of endodontic materials can affect the inflammatory response and repair processes, 10 and also interfere with systemic health since these materials release toxic substances.
11,12
Although the relationship between AP and systemic disorders has already been documented, 13, 14 the tissue response to biomaterials depends on the immune response, 15, 16 so systemic disorders can alter immune function and affect the healing process.
14 Moreover, irrespective of the systemic condition, endodontic materials should show satisfactory physicochemical and biological properties and also the ability to promote healing. Therefore, the second objective of this review was to discuss both the systemic effects of endodontic materials and the correlation between systemic conditions and endodontic materials.
Methodology
In the present study, a search was performed in the PubMed online database to identify the available basic research articles, reviews, and case reports on the relationship between endodontic infection and systemic diseases or that between dental materials and systemic diseases. The search included only articles in endodontic area published in English in indexed dental or medical journals. The selected articles were included only when they were judged to contain relevant and pertinent information by the authors of this study.
Systemic conditions and their relationship with apical periodontitis (Table 1) Effects of endodontic infection on the normal systemic condition
There are multiple studies identifying AP as a factor that can potentiate the symptoms caused by inflammatory diseases such as diabetes. 6, [17] [18] [19] However, there is limited evidence in the literature showing AP as the primary cause of systemic disorders. Studies in humans and animals have been conducted in order to determine systemic molecular changes in the body of individuals with no systemic disorders, but with AP.
Some studies were performed to assess the possible influence of AP on insulin resistance, which can increase the risk of diabetes.
Astolphi et al. 20, 21 used a rat model of AP induced by pulp exposure to show that the presence of AP may cause alterations in both insulin signaling and insulin sensitivity in serum and skeletal muscle, probably because of elevated plasma TNF-α levels. Moreover, Pereira et al. 22 found that AP promoted an increase in macrophage infiltration, inflammatory pathway activation in muscle tissue, and serum concentrations of heat shock protein and lipopolysaccharide in rats.
Regarding systemic inflammatory markers, Cintra et al. 7 performed a study using a rat model of pulp exposure-induced AP. The results showed that the presence of one AP focus did not alter the expression of proinflammatory cytokines systemically. However, the presence of four AP foci increased the serum levels of interleukin (IL)-6, IL-17, IL-23, and TNF-α and decreased the NO synthase levels. These results suggest that the inflammatory changes reflect the amount of local inflammation. In addition, Samuel et al. 5 observed that the presence of four AP foci is related to an increase in the levels of leukocytes, lymphocytes, and TNF-α, and a decrease in serum IL-4 levels. Moreover, Zhang et al. 23 showed that AP elevated the levels of C-reactive protein (CRP), IL-2, and IL-6 in rat blood serum, causing reversible changes in the aortic arch, myocardium, and spleen as well as irreversible changes in the liver. The authors concluded that AP may trigger 24 evaluated the impact of chronic apical periodontitis on oxidative stress. Oxidative stress is a "disturbance in the pro-oxidant-antioxidant balance in favor of the former, leading to a disruption in redox signaling and/or molecular damage." 25 In this context, the authors conducted a study in which the oxidative balance in both patients with chronic AP and healthy control participants was determined by measuring the oxidant status using a test for identification of the reactive oxygen metabolites (d-ROMs), while the antioxidant status in these patients was determined using a biological antioxidant potential (BAP) test. The tests were conducted before endodontic treatment and 30 and 90 days after the treatment. The results showed that, on recruitment, patients with chronic AP exhibited significantly higher levels of oxidative stress than controls, as determined by the d-ROM and BAP tests. Furthermore, the d-ROM test values decreased and the BAP test values increased over time in patients with chronic AP following endodontic therapy. The levels of oxidative stress in these patients tended to reduce and return to normal by 90 days following treatment.
24
It is possible to infer that studies on the impact of endodontic infection on systemic health have been increasing, which shows that it is very important to conduct more studies to better understand these connections and outcomes..
Bidirectional relationship between systemic disorders and endodontic infection a. Diabetes and endodontic infection
Many clinicians and researchers have studied the interrelationship between oral infections and systemic disorders. The bidirectional relationship between endodontic infection and the systemic metabolic disease diabetes has been one of the targets of studies to better understand the connections between local and systemic inflammatory processes. It is well established that diabetes can influence the pathogenesis of AP, especially its severity and development. The first paper describing the influence of diabetes on the pathogenesis of AP was published in 1996 by Kohsaka et al., 26 which showed that inflammation in the periodontal ligament of the periapical area, root resorption, and bone alveolar loss were more severe in diabetic rats compared to the control group. Consequently, lesions in the periapical area were larger in diabetic rats compared to those in the control group.
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Subsequently, other animal studies 6, [27] [28] [29] [30] [31] comparing the severity of inflammation and periapical bone loss between patients with diabetes and normoglycemic controls were conducted and are in agreement with the findings obtained by Kohsaka et al. 26 In addition, one of these studies showed that diabetes may enhance the production of IL-17 in the AP site of rats, 31 confirming that diabetes may influence the inflammatory process in periapical tissues of rats with endodontic infection.
In humans, several studies have been performed in order to study the correlation between the prevalence of AP and diabetes. Segura-Egea et al. 32 performed a retrospective study using the records of 38 diabetic and 32 normoglycemic subjects. Their study showed AP in at least one tooth in 81.23% of diabetic patients and 58% of control subjects. The authors concluded that type 2 diabetes mellitus is significantly associated with an increased prevalence of AP. Later, López-López et al. 33 performed a cross-sectional study using the radiographic records of 50 diabetic patients and 50 normoglycemic subjects. The results showed that AP in one or more teeth was present in 74% of diabetic patients and 42% of control subjects. Among diabetic patients with root-filled teeth, 46% had AP affecting at least one treated tooth and 24% of the controls had AP affecting at least one treated tooth. After adjusting for teeth number, multivariate logistic regression analysis showed that periapical status and the number of rootfilled teeth were significantly associated with diabetic status. In addition, Marotta et al. 34 conducted a crosssectional study that showed that AP was significantly more prevalent in untreated teeth from patients with type 2 diabetes. According to the authors, diabetes may serve as a disease modifier of AP in the sense that individuals with diabetes can be more prone to develop primary disease. In agreement with the previous studies, Smadi 35 found that there is a higher prevalence of AP in diabetes mellitus patients compared with that in the nondiabetic group, with an increased prevalence of persistent chronic AP. In comparison with well-controlled diabetes, poor glycemic control may be associated with a higher prevalence of AP and an increased rate of endodontic failures. Despite the results correlating the higher prevalence of AP with diabetic status, Tibúrcio-Machado et al., 36 in a critical review, concluded that the results presented in the literature were still scarce and incipient and the evidence for such an association was not yet conclusive. However, the published results trend to converge on a positive association between diabetes and a larger number of periapical lesions.
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Regarding the severity and lesion size, Rudranaik et al. 37 concluded that diabetic patients with chronic AP have larger lesions and delayed healing outcomes when compared to normoglycemic patients.
In order to obtain a more precise prognosis of endodontic treatment in diabetic patients, many studies have been performed to compare the healing outcomes after conventional endodontic treatment between diabetic and normoglycemic patients. Fouad and Burleson 38 performed conventional endodontic treatment in 284 diabetic patients and followed up 73 of them for two years postoperatively. Patients with diabetes showed increased periodontal disease of teeth with endodontic involvement compared with normoglycemic patients. There was a trend toward increased symptomatic periradicular disease in patients with diabetes who received insulin, as well as flare-ups in all diabetic patients. In addition, the presence of diabetes was associated with significantly reduced successful outcomes. 38 Moreover, Brito et al.
39
evaluated the records of 30 diabetic individuals and 23 control subjects and found that men with type 2 diabetes who received endodontic treatment were more likely to have refractory lesions after endodontic treatment. In accordance with these previous studies, Segura-Egea et al. 40 performed a systematic review and meta-analysis that showed that diabetic patients have a higher prevalence of AP in endodontically treated teeth. Thus, diabetes is an important putative pre-operative prognostic factor in root canal treatment. However, Marotta et al. 34 performed a cross-sectional study that showed no significant difference between patients with and without diabetes when the prevalence of AP in root canal-treated teeth, the number of teeth in the oral cavity, the number of treated teeth per individual, the number of individuals with at least 1 AP lesion or one root canal treatment, and the number of teeth with AP per individual were evaluated. Recently, Arya et al. 19 observed that both the diabetic and nondiabetic groups showed a significant reduction in the periapical score after endodontic treatment at the 12-month follow-up. In addition, significantly less periapical healing was observed in the diabetic group (43%) compared with the nondiabetic group (80%) at the 12-month follow-up.
At present, studies have established that while diabetes can influence the pathogenesis of AP, AP can also potentiate the systemic effects occurring as a consequence of diabetes.
Schulze et al. 17 presented a case report showing a sudden increase in patient blood glucose levels during exacerbation of a combined endodonticperiodontic lesion. Forty days after the endodontic treatment, the insulin dosage was comparable to that taken before the endodontic-periodontic lesion exacerbation. Thus, the authors concluded that there is a relevant correlation between insulin resistance and the presence of a local dental inflammation, which shows the importance of conventional endodontic treatment in the non-vital teeth of diabetic patients.
In addition, studies using animal models have shown that AP in combination with periodontal disease can potentiate the systemic effects of diabetes. These effects may be represented by an increase in triglyceride levels, 41 HbA1c serum levels, 28 proinflammatory cytokine IL-17 levels, 30 inflammatory cells in the blood, 29 and platelets. 42 In addition, the studies showed that the associations among AP, PD, and diabetes increased the weights of the brain, heart, and gonads and the total body weight of rats. 43 According to the authors, these results demonstrate that AP can affect the body system. 43 Another study using an animal model showed how AP can affect the oxidative stress parameters in the presence of diabetes. 6 The findings showed that AP might potentiate diabetes pathogenesis, increasing the levels of uric acid, which serve as a marker for chronic kidney disease. 6 In addition, AP not only increases the levels of the antioxidant uric acid, but also decreases the levels of the antioxidant albumin, confirming that it can enhance the pathogenesis of diabetes.
The authors emphasized that these findings are very important because they suggest that the treatment and management of AP might improve the systemic oxidative condition induced by diabetes.
6
In humans, Sánchez-Domingues et al. 18 performed a cross-sectional study in which a worse periapical status was correlated with higher HbA1c levels in diabetic patients, supporting the findings of previous studies performed in animals. 28 Arya et al. 19 observed that HbA1c levels in diabetic patients increased at each follow-up examination after endodontic treatment.
Taken together, these studies strongly suggest a bidirectional relationship between endodontic infection and diabetes, highlighting the importance of endodontic treatment in improving systemic health condition.
b. Cardiovascular diseases and endodontic infection
Another possible systemic alteration linked to AP is cardiovascular disease, which has been intriguing many researches since few studies have addressed the association between them. These studies assessed the alterations represented by coronary artery disease, 44, 45, 46 acute coronary syndrome, 4 and hypertension.
47,48
There are some studies in the literature that associated the presence of AP with cardiovascular diseases. Caplan et al. 46 evaluated whether incident radiographically evident lesions of endodontic origin were related to the development of coronary heart disease (CHD) in 708 patients. The results showed a relationship between AP and CHD in patients aged under 40 years. These results were confirmed later by Gomes et al., 49 who showed that the endodontic burden in midlife was an independent predictor of CVE among community-dwelling participants. However, Pasquilini et al. 45 designed a case-controlled clinical trial using 51 patients with acute myocardial infarction or unstable angina and 40 healthy controls, which did not show evidence indicating a correlation between AP and CHD. Subsequently, Costa et al.
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performed a cross-sectional study including 103 patients who underwent coronary angiography and found that patients with chronic AP had a 2.79-fold higher risk of developing coronary artery disease. Moreover, An et al. 51 observed that subjects with AP were 5.3-fold more likely to have CVD than subjects without AP. In addition, Liljestrand et al. 4 
as well as
Virtanen et al. 52 concluded that AP is associated with cardiovascular disease. In addition, Lijestrand et al. 4 concluded that AP is associated independently with CAD and, in particular, acute coronary syndrome, consolidating the role of oral conditions in evaluating total cardiovascular risk.
Regarding the association between hypertension and AP, Segura-Egea et al. found that hypertension is associated with the presence of AP 53 and tobacco can increase that prevalence.
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Although there is evidence for the correlation between cardiovascular diseases and AP, more studies should be performed to better elucidate the mechanisms associated with those events. Rashimi et al. 47 measured the levels of CRP, which is a biomarker for cardiovascular diseases, as well as the proinflammatory cytokine IL-6 and fibrinogen. They found that in hypertensive patients, AP alters the systemic levels of inflammatory markers such as CRP, IL-6, and fibrinogen. In addition, another study demonstrated that elevated levels of the receptors sTNF-R1 and sTNF-R2, which are markers for the activity of the proinflammatory cytokine TNF-α, 55 were found in periodontal disease patients, indicating an increased independent risk of CHD in these patients. 44 Regarding the possible influence of cardiovascular diseases on AP progression, one study found that hypertension did not influence the expression of proinflammatory mediators or the periapical lesion size in mice. However, the hypertension group showed elevated osteoclast differentiation in vitro.
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In conclusion, there is evidence suggesting that endodontic infection and cardiovascular diseases are correlated. However, more studies should be conducted to better understand the pathways and possible targets related to those interactions, in order to control the consequences of both diseases.
c. Other systemic disorders and endodontic infection
Although diabetes and cardiovascular diseases are the most explored systemic disorders related to AP, other studies have been performed to determine the bidirectionality between AP and other systemic diseases.
Khalighinejad et al. 56 performed a cross-sectional study to evaluate the presence of AP in patients with end-stage renal disease (ESRD) in comparison with that in patients with no history of ESRD. The results showed AP in 73% of patients with ESRD and in 40% of control patients. In addition, 52% of the patients with ESRD had at least one endodontically treated tooth, while the control group value was 28%. Moreover, they found that the number of teeth with AP was significantly associated with the serum urea levels in the experimental group. The authors concluded that ESRD could possibly alter the pathogenesis of AP. However, these findings do not confirm the presence of any cause-and-effect relationship between these conditions. Nevertheless, considering the modifying effect of AP on serum urea levels, treatment of AP could be incorporated in the treatment planning of patients with ESRD.
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The same research group performed a study investigating the association between maternal AP and preeclampsia (PE) in patients. 57 The results of this case-control study showed that AP in at least one tooth was found in 54% of the mothers who develop PE in comparison with 16% of the mothers with a normal course of pregnancy. The authors concluded that this study provided evidence that maternal AP may be a strong independent predictor of PE. 57 Piras et al. 58 evaluated the prevalence of AP in patients with inflammatory bowel disease (IBD) treated with immunomodulators. In their study, the patients underwent a complete oral, dental, and radiographic examination. They found that women with IBD taking immunomodulators had a higher prevalence of AP. In addition, all patients with IBD had larger AP lesions than healthy subjects.
Grønkjaer et al. 59 observed the prevalence of AP in patients with cirrhosis and the association with systemic inflammation status and cirrhosis-related complications. The results revealed that patients with AP had higher CRP and lower albumin levels than those without AP. Furthermore, patients with AP showed a higher prevalence of cirrhosis-related complications such as ascites, hepatic encephalopathy, and/or variceal bleeding.
Gomes-Filho et al. 60, 61 showed that hypoestrogenia may stimulate osteoclastogenesis and osteoclast activity, increasing the levels of RANKL and inflammatory cells, during the progression of AP. As a consequence, hypoestrogenia potentiates bone resorption in the periapical tissues of rats with endodontic infection.
Thus, these findings indicate that there are many possible bidirectional relationships between endodontic infection and systemic disorders. Although more studies should be performed to better comprehend these interactions, eradicating the focus of infection should be one of the goals to improve systemic health.
Systemic conditions and their relationships with dental materials
Systemic effects of dental materials (Table 2) Dental materials are routinely used in dental practice, including direct restorative materials, bonding materials, composites, acrylic resins, endodontic sealers, pulp-capping materials, root end-filling materials, and substances for release either into the oral environment or into body fluids. 12, 62, 63, 64 Thus, once these materials are in direct contact with dental tissues (dental pulp, cementum, alveolar bone, and the periodontal ligament), their chemical composition can interfere with and consequently affect the tissue response and repair process, 10 and also compromise systemic health. 12, 64 Therefore, studies have been conducted to evaluate the potential risks of these materials to body organs. 11, 62, 64, 65, 66 Al-Hiyasat et al. 67 suggested that leached substances from resin-based dental composite materials have an adverse effect on the fertility and reproductive system of male mice. Fakhouri et al. 68 demonstrated that the administration of high concentrations of methyl methacrylate is associated with seminal vesicle atrophy in rats. In addition, higher concentrations of methyl methacrylate are also related to alterations or lesions in several organs, such as the liver, kidney, brain, and lung. 69, 70 Furthermore, Ballestri et al.
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assessed the presence of granulomatosis in the liver and kidney of patients with malocclusion, bruxism, and worn dental prostheses and suggested that the systemic foreign body granulomatosis found in these patients can be associated with worn dental prostheses, since the particles isolated from the liver-kidney granulomas contained feldspars, the main component of porcelain.
With respect to endodontic materials, it has already been described that endodontic sealers can release heavy metals 71, 72 even after setting. 73 These metals/ ions can enter the bloodstream and be transported to distant tissue sites, which may leave traces on some organs and affect their metabolism. 11, 12 The rate of element/ion release will vary considerably depending on the chemical composition, ionic dissolution, and setting time of the material. 72, 73, 74, 75 The first study reporting the impact of endodontic sealers on the concentrations of trace ions in body organs was performed by Economides et al., 76 which verified the concentrations of zinc and calcium in the brain, liver, kidneys, and uterus of rats at 7 days after subcutaneous implantation of AH-26, Roth 811, CRCS, and Sealapex sealers, and reported that AH-26 induced an increase in calcium levels and CRCS increased zinc concentrations in all organs examined, whereas the liver zinc concentration increased and calcium concentration in all body organs decreased in the presence of the Roth 811 sealer. Furthermore, Kolokouris et al. 77 injected Roth 811 into the dorsal thoracic of rats and analyzed the zinc, calcium, and copper concentrations in the liver, heart, kidney, and brain. The authors verified the concentrations every day over 7 days and reported that the Roth 811 injections mainly on the 4 th and 5 th days, altered the zinc, calcium, and copper concentrations in body organs.
Khalil and Eid 65 noted that MTA promoted changes in the liver and kidney. The authors investigated and compared the systemic toxic effects of DiaRoot BioAggregate and ProRoot MTA on the liver and kidney 7 and 30 days after direct application to the connective tissue of rats and observed severe inflammatory reactions in the presence of both sealers, which decreased with time. Additionally, they analyzed serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels to assess liver function and urea and creatinine levels to verify kidney function. Kidney function was not affected, but a continuous increase in the liver function markers was detected in the presence of MTA. In a similar investigation, the systemic effects of MTA and EndoBinder were also evaluated in the liver and kidney by Garcia et al. 66 They reported that both sealers caused severe inflammatory reactions in the body organs, but in the MTA group, these reactions were more accentuated. In addition, an increase in liver function marker levels was also detected in the presence of MTA.
Simsek et al. 12 analyzed the levels of seven ions, namely, beryllium, magnesium, aluminum, calcium, chromium, arsenic, and lead, in the brain, liver, and kidneys of rats 45 days after implantation of Micro Mega MTA, Bioaggregate, and Biodentine materials in subcutaneous tissue, and demonstrated higher levels of chromium in the brain and kidney samples and magnesium in the kidney and liver samples. Chromium, in particular the hexavalent chromium, is a wellknown human carcinogen. 78 Renal insufficiency and neuromuscular and cardiovascular toxicity can be linked to hypermagnesemia. 79 However, even with the elevated levels of these metals in the brain, kidney, and liver samples, all sealers were considered nontoxic to these body organs, since the increase was below the toxic levels for trace elements.
The effects of both Gray and White MTA on systemic bone marker expression at 7 and 30 days after subcutaneous implantation in rats were investigated. Calcium, phosphorus, and serum alkaline phosphatase levels were measured, and the calcium and phosphorus levels increased at 7 days and decreased with time; however, alkaline phosphatase levels remained unaltered. 80 In addition, hypercalcemia can cause renal insufficiency, neurologic injuries, and anorexia, whereas hyperphosphatemia caused vascular and soft-tissue calcifications. 79 
Demirkaya et al.
11 used a dental extraction socket model to verify the effects of MTA Angelus, MTA Fillapex, and Theracal LC on aluminum levels in the plasma and liver at 7, 30, and 60 days. The authors reported that plasma aluminum levels were higher in the presence of MTA Angelus and MTA Fillapex; however, no differences in aluminum levels in liver samples were identified.
Furthermore, in another report, Demirkaya et al. 64 examined the effects of MTA Angelus, MTA Fillapex, and Theracal LC on aluminum levels and oxidative stress parameters by analysis of thiobarbituric acid reactive substances (TBARS) levels and catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GPx) activities in the brain at 7, 30 and 60 days. A transient increase in brain aluminum levels was detected in the MTA Angelus group at 7 days; in contrast, the MTA Fillapex and Theracal LC groups showed the highest levels only on day 60. Additionally, the TBARS levels and CAT, SOD, and GPx activities in brain were transiently upregulated at 7 days. Moreover, due to the aluminum neurotoxicity, the presence of this metal in brain tissue induces oxidative stress, which can be related to the pathogenesis of some neurological illnesses such as Alzheimer's disease and Parkinson's disease, 81 as well as skeletal and hematological changes.
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In a complementary study, Demirkaya et al. 73 evaluated if the oxidative stress parameters in erythrocytes and liver were altered in the presence of these same materials and showed that all sealers promoted a transient increase in TBARS levels, which is a biomarker of lipid peroxidation, and in the activity levels of antioxidant enzymes in erythrocytes and the liver. In addition, the MTA Angelus group showed the highest erythrocyte and liver TBARS concentrations at 7 days. It is important to highlight that induction of oxidative stress even with a transient increase can promote systemic effects, including dementia, Alzheimer's and Parkinson's disease, 83 and variations in behavioral and cognitive function.
84 Furthermore, the elevated levels of lipid peroxidation products are associated with atherosclerosis 85 and kidney disease.
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Therefore, considering the fact that only a few investigations have been performed to assess the systemic effect of endodontic sealers, it is clear that further studies are necessary to elucidate their possible toxic effects, as this relationship is not yet completely understood.
Systemic conditions and dental materials (Table 3) The con nections/associations among AP, chronic inflammatory processes of infectious origin, and systemic diseases such as diabetes mellitus, cardiovascular disease, osteoporosis, a lcohol ism, l iver disease, a nd coag u lat ion disorders are well-known. 13, 14 Although the impact of these disorders on periapical healing has been investigated, there is little information available concerning the correlation between systemic conditions and oral diseases with regard to the pulpal healing behavior after endodontic procedu res or even t he t issue respon se to endodontic materials.
Independent of the systemic condition, dental materials should be biocompatible and have the ability to achieve healing. Some in vivo and in vitro studies have been developed to elucidate this relationship. 48, 87 In addition, animal models that simulate systemic conditions, such as diabetes mellitus and hypertension, have also been employed. 48, 87 d. Diabetes and dental materials Diabetes mellitus is a metabolic disease considered to be a modulator of endodontic infections, 88 and it is responsible for altering the immune and inflammatory response, undermining the healing process, and promoting damage to body organs and tissues, including the dental pulp and periapical tissues. 89, 90, 91 Garber et al. 92 verified the effect of hyperglycemia on pulpal healing in exposed rat pulpal tissue that was capped with MTA at 30 days and revealed an increase in pulp inflammation and inhibition of dentin bridge formation in diabetic rats, showing that the hyperglycemic state adversely affected pulpal healing. In another study, Madani et al. 93 compared the effects of MTA or calcium-enriched mixture cement on dental pulp response to pulpcapping in diabetic rats. The authors analyzed the intensity of inflammation, dentin bridge formation, and dentin bridge continuity and reported an increase in the number of inflammatory cells under diabetic conditions; in addition, they identified differences in dentin bridge formation, dentin bridge continuity, and the number of inflammatory cells among the groups treated with MTA or calcium-enriched mixture. In contrast, since the diabetic rats treated with MTA did not exhibit a significantly higher inflammatory response in comparison to healthy controls, the authors suggested that MTA is a superior material for pulp therapy under diabetic conditions. Gomes-Filho et al. 87 investigated the effects of diabetes on the tissue response and mineralization ability of MTA and revealed that diabetes did not influence the tissue response to MTA or the mineralization stimulated by it. In addition, no evidence of the direct correlation among diabetes mellitus and inflammatory response or mineralization ability for Sealapex and MTA Fillapex sealers was detected in a similar investigation.
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Furthermore, the local and systemic effects of both Gray and White MTA on bone marker expression after subcutaneous implantation in diabetic rats were investigated by Queiroz et al. 80 Immunohistochemical analysis of osteocalcin and osteopontin production and biochemical analyses of calcium, phosphorus, and serum alkaline phosphatase levels at 7 and 30 days were performed. At day 7, calcium and phosphorus levels were higher in the GMTA group than in the WMTA group. At both time points, alkaline phosphatase activity was higher; moreover, an increase in phosphorus levels was observed at 30 days. Besides, under diabetic conditions, both MTAs had an inhibitory effect on osteocalcin and osteopontin production. Although scientific evidence shows that hyperglycemia leads to an increase in inflammation and calcification and undermines dentin bridge formation on the dental pulp, 91, 92 the effect of dental bleaching procedures on the pulp under diabetic conditions remains unclear.
Cintra et al. 95 examined the inflammatory response and maturation of collagen fibers in the pulp tissue of maxillary molars after dental bleaching with 35% hydrogen peroxide gel for 30 min in healthy and diabetic rats and reported an increase in the inflammatory response, a reduction in the pulp chamber area by deposition of reactionary dentine, and an increase in mature collagen fibers in the diabetic bleaching group. In a complementary study, the effect of tooth bleaching with 35% hydrogen peroxide gel on the production of the immunoregulatory cytokines IL-6, TNF-α, and IL-17 in the pulp tissue under diabetic conditions was also evaluated by Ferreira et al. 96 Irrespective of the diabetes condition, tooth bleaching increased IL-6 and TNF-α production. Nevertheless, higher levels of inflammation and TNF-α level were observed in diabetic rats. Regardless of IL-17 production, an increase was detected in the early periods in healthy rats. e. Hypertension and dental materials Hypertension is defined as a chronic and inflammatory disorder 97 and is considered a risk factor for both oral and systemic disease. Chronic kidney failure, atherosclerosis, heart attack, stroke, cerebrovascular disease, and dementia 98, 99 as well as periodontitis and apical periodontitis 54, 100, 101 have been reported to be associated with hypertension. Although the relationship between hypertension and periapical lesions has been described, 14, 48 the effect of endodontic materials on pulp and periapical tissue under hypertensive conditions remains unclear.
Martins et al. 101 evaluated the effect of hypertension on tissue response and the mineralization capacity of Gray MTA, White MTA, and IRM (intermediate restorative material) at 7 and 30 days and observed an intense inflammatory response in hypertensive rats in the presence of all sealers. Even under hypertensive conditions, both MTAs were capable of promoting mineralization; however, a decrease in the mineralization rate was detected in hypertensive rats. Thus, the authors suggested that hypertension could impair the tissue response and mineralization ability of MTA.
Since hypertension is associated with alterations in bone metabolism and a reduction in bone mineral density and mineralization ability due to the calcium loss in bones, 102 Martins et al. 103 investigated the mineralization ability of both Gray and White MTA and IRM sealers implanted on the subcutaneous tissue of normal and hypertensive rats. Immunohistochemical analysis of osteoblastic biomarkers showed a decrease in the production of the RUNX-2, OCN and OPN biomarkers in the presence of both MTAs under hypertensive conditions. Further, regardless of the systemic condition, no biomarker production was observed in the IRM group.
Considering the fact that there is only limited information concerning the links between systemic conditions and endodontic materials, it is evident that more research should be conducted to elucidate this relationship, including the possible systemic effects.
